These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6163516)

  • 1. Effects of glutamate and aspartate on ataxic gait induced by 3-acetyl pyridine in rats.
    DeMichele G; Jolicoeur FB; Rondeau DB; Butterworth RF; Barbeau A
    Can J Neurol Sci; 1980 Nov; 7(4):451-4. PubMed ID: 6163516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate and aspartate do not modify the ataxic gait of acrylamide treated animals.
    De Michele G; Jolicoeur FB; Barbeau A
    Can J Neurol Sci; 1982 May; 9(2):179-80. PubMed ID: 6125254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of YM-14673, a new thyrotropin releasing hormone analogue, on ataxic gait in cytosine arabinoside-treated mice.
    Yamamoto M; Shimizu M
    Eur J Pharmacol; 1989 Aug; 166(3):545-7. PubMed ID: 2509218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals.
    Kinoshita K; Fujitsuka T; Yamamura M; Matsuoka Y
    Eur J Pharmacol; 1995 Feb; 274(1-3):65-72. PubMed ID: 7768282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin-releasing hormone and its receptor in the cerebellum of inferior olive destroyed rat brain.
    Adachi K; Rhue BN; Li M; Izumi M; Osano H; Mitsuma T
    Neurol Res; 2000 Jun; 22(4):401-3. PubMed ID: 10874690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histydyl-proline diketopiperazine (HPD), a metabolite of thyrotropin-releasing hormone (TRH), improves the ataxic gait in 3-acetylpyridine (3-AP) treated rats].
    Kurahashi K; Kannari K; Kimura K; Matsunaga M; Takebe K
    No To Shinkei; 1986 Sep; 38(9):893-8. PubMed ID: 3790371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the behavioral pharmacology of TRH-T in cytosine arabinoside-induced ataxic mice: a comparison with genetically ataxic mice].
    Matsui K; Mano Y; Mukoyama M; Muramoto O; Toyoshima E; Ando K
    Jikken Dobutsu; 1983 Jan; 32(1):13-9. PubMed ID: 6406242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of serotonin, substance P and thyrotropin-releasing hormone on excitability of rat spinal motoneurons in vivo.
    White SR
    Brain Res; 1985 May; 335(1):63-70. PubMed ID: 2408702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intranasal administration of thyrotropin-releasing hormone on ataxic gait in staggerer mice.
    Matsui K; Itoh K; Mizumachi M; Kubo H; Goto T; Sato S; Wada K
    Neurosci Lett; 1996 Jul; 212(2):115-8. PubMed ID: 8832652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin-releasing hormone (protirelin) inhibits potassium-stimulated glutamate and aspartate release from hippocampal slices in vitro.
    Nie Y; Schoepp DD; Klaunig JE; Yard M; Lahiri DK; Kubek MJ
    Brain Res; 2005 Aug; 1054(1):45-54. PubMed ID: 16055093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aspartate and glutamate on carbon tetrachloride induced liver damage in rats.
    Singh J; Garg KN; Mehrotra GC
    Indian J Exp Biol; 1990 Dec; 28(12):1180-3. PubMed ID: 2099335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRH receptor agonists ameliorate 3-acetylpyridine-induced ataxia through NMDA receptors in rats.
    Kinoshita K; Watanabe Y; Yamamura M; Matsuoka Y
    Eur J Pharmacol; 1998 Feb; 343(2-3):129-33. PubMed ID: 9570459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ataxia in rolling mouse Nagoya and the norepinephrine system--a psychopharmacological study].
    Matsui K; Toyoshima E; Mano U; Ando K
    Yakubutsu Seishin Kodo; 1982 Dec; 2(2):77-80. PubMed ID: 6821292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of DN-1417 on ataxia in Rolling mouse Nagoya and Staggerer mouse in comparison with the effect of TRH].
    Matsui K; Mano Y; Ando K
    Yakubutsu Seishin Kodo; 1986 Jun; 6(2):281-3. PubMed ID: 3096012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-, substance P- and glutamate/aspartate-like immunoreactivities in medullo-spinal pathways of rat and primate.
    Nicholas AP; Pieribone VA; Arvidsson U; Hökfelt T
    Neuroscience; 1992; 48(3):545-59. PubMed ID: 1376453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of DN-1417, a synthetic thyrotropin-releasing hormone analogue, on [3H]GABA binding in the cerebellum of ataxic rats.
    Tatsuoka Y; Kato Y; Imura H
    Neurosci Lett; 1985 Jan; 53(1):63-8. PubMed ID: 2986054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new method for evaluation of motor deficits in 3-acetylpyridine-treated rats.
    Watanabe Y; Kinoshita K; Koguchi A; Yamamura M
    J Neurosci Methods; 1997 Nov; 77(1):25-9. PubMed ID: 9402553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic abnormalities caused by 3-acetylpyridine in the cerebral motor regions of rats: partial recovery by thyrotropin-releasing hormone.
    Kinoshita K; Watanabe Y; Asai H; Matsuoka Y
    Jpn J Pharmacol; 2000 Apr; 82(4):295-300. PubMed ID: 10875748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacological effect of thyrotropin-releasing hormone on ataxic mutant mice.
    Mano Y; Matsui K; Toyoshima E; Ando K
    Acta Neurol Scand; 1986 Apr; 73(4):352-8. PubMed ID: 3088901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thyrotropin releasing hormone (TRH) on glutamate-induced seizures in rats.
    Yoshida M; Izumi K; Nakanishi T
    Tohoku J Exp Med; 1987 Jul; 152(3):311-7. PubMed ID: 2889280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.